TAB AMOXYCLAV 375MG,TAB LANSOPRAZOLE 15MG,TABLET ACETYLCYSTEINE AMBROXOL,TABLET ACECLOFENAC,TAB ACE
Border Security Force (bsf)
COOCH BEHAR, WEST BENGAL
Bid Publish Date
25-Jun-2025, 11:09 am
Bid End Date
16-Jul-2025, 12:00 pm
EMD
₹20,337
Location
Progress
RAQuantity
10687
Category
Cap Midostaurin 25 mg
Bid Type
Two Packet Bid
Indian Army invites bids for Cap Midostaurin 25 mg, Tab Venetoclax 100 mg, Tab Azacitidine 300 mg, Inj Cyclosporine 50 mg, Cyclophosphamide 500 mg Inj, Cytosine Arabinoside 500 mg Inj, Cytosine Arabinoside Preservative free 100 mg Inj, Daunorubicin 20 mg Inj, Mercaptopurine 50 mg Tab, Inj Methotrexate 500mg, Mesna 200mg Inj, Tab Ruxolitinib 20 mg, Al trans retinoic Acid 10 mg Cap, Zoledronic Acid 5 mg Inj, Idarubicin 5mg slace ml Inj, Desferrioxamine 500 mg Inj, Lenalidomide 10 mg Cap, 3rd Gen Recombinant Factor VIII Injection 500 IU, Inj Decitabine 50 mg, Inj Brentuximab Vedotin 50 mg, Inj Crizanlizumab 10 mg slace ml 10ml, inj isavuconazole 200 mg, Inj Luspatercept 25 mg, Inj Luspatercept 75 mg, Inj Peg Asparaginase 3750 U, Inj Rasburicase 1 point 5 mg, Inj Romiplostim 250 mcg, Inj Romiplostim 125 mg, Inj Thiotepa 100 mg, Inj Thiotepa 15 mg, Inj Treosulfan 5 gm, Tab Pomalidomide 2 mg, Inj Feiba 500 IU, Tab Posaconazole 100 mg, Polatuzumanb Vedotin 30 mg, Nonacog beta pegol 500 IU Lyophilized powder for solution for Injection Glycopegylated Recombinant Factor IX in KOLKATA, WEST BENGAL. Quantity: 10687. Submission Deadline: 16-07-2025 12: 00: 00. Submit your proposal before the deadline.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Border Security Force (bsf)
COOCH BEHAR, WEST BENGAL
Indian Army
EAST SIKKIM, SIKKIM
Indian Army
Indian Army
HYDERABAD, TELANGANA
Indian Army
LEH, JAMMU & KASHMIR
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Cap Midostaurin 25 mg | Cap Midostaurin 25 mg | 600 | nos | consignee2dglp | 30 |
| 2 | Tab Venetoclax 100 mg | Tab Venetoclax 100 mg | 720 | no | consignee2dglp | 30 |
| 3 | Tab Azacitidine 300 mg | Tab Azacitidine 300 mg | 300 | nos | consignee2dglp | 30 |
| 4 | Inj Cyclosporine 50 mg | Inj Cyclosporine 50 mg | 300 | vial | consignee2dglp | 30 |
| 5 | Cyclophosphamide 500 mg Inj | Cyclophosphamide 500 mg Inj | 72 | amp slace vial | consignee2dglp | 30 |
| 6 | Cytosine Arabinoside 500 mg Inj | Cytosine Arabinoside 500 mg Inj | 150 | amp slace vial | consignee2dglp | 30 |
| 7 | Cytosine Arabinoside Preservative free 100 mg Inj | Cytosine Arabinoside (Preservative free) 100 mg Inj | 90 | amp slace vial | consignee2dglp | 30 |
| 8 | Daunorubicin 20 mg Inj | Daunorubicin 20 mg Inj | 30 | amp slace vial | consignee2dglp | 30 |
| 9 | Mercaptopurine 50 mg Tab | Mercaptopurine 50 mg Tab | 1,200 | no | consignee2dglp | 30 |
| 10 | Inj Methotrexate 500mg | Inj Methotrexate 500mg | 240 | vial | consignee2dglp | 30 |
| 11 | Mesna 200mg Inj | Mesna 200mg Inj | 60 | amp slace vial | consignee2dglp | 30 |
| 12 | Tab Ruxolitinib 20 mg | Tab Ruxolitinib 20 mg | 300 | no | consignee2dglp | 30 |
| 13 | Al trans retinoic Acid 10 mg Cap | Al trans retinoic Acid 10 mg Cap | 540 | no | consignee2dglp | 30 |
| 14 | Zoledronic Acid 5 mg Inj | Zoledronic Acid 5 mg Inj | 30 | amp slace vial | consignee2dglp | 30 |
| 15 | Idarubicin 5mg slace ml Inj | Idarubicin 5mg slace ml Inj | 30 | vial | consignee2dglp | 30 |
| 16 | Desferrioxamine 500 mg Inj | Desferrioxamine 500 mg Inj | 30 | amp slace vial | consignee2dglp | 30 |
| 17 | Lenalidomide 10 mg Cap | Lenalidomide 10 mg Cap | 3,000 | no | consignee2dglp | 30 |
| 18 | 3rd Gen Recombinant Factor VIII Injection 500 IU | 3rd Gen Recombinant Factor VIII Injection 500 IU | 168 | vial | consignee2dglp | 30 |
| 19 | Inj Decitabine 50 mg | Inj Decitabine 50 mg | 90 | vial | consignee2dglp | 30 |
| 20 | Inj Brentuximab Vedotin 50 mg | Inj Brentuximab Vedotin 50 mg | 18 | vial | consignee2dglp | 30 |
| 21 | Inj Crizanlizumab 10 mg slace ml 10ml | Inj Crizanlizumab 10 mg slace ml (10ml) | 18 | vial | consignee2dglp | 30 |
| 22 | inj isavuconazole 200 mg | inj isavuconazole 200 mg | 30 | vial | consignee2dglp | 30 |
| 23 | Inj Luspatercept 25 mg | Inj Luspatercept 25 mg | 36 | vial | consignee2dglp | 30 |
| 24 | Inj Luspatercept 75 mg | Inj Luspatercept 75 mg | 24 | vial | consignee2dglp | 30 |
| 25 | Inj Peg Asparaginase 3750 U | Inj Peg Asparaginase 3750 U | 12 | vial | consignee2dglp | 30 |
| 26 | Inj Rasburicase 1 point 5 mg | Inj Rasburicase 1.5 mg | 6 | amp | consignee2dglp | 30 |
| 27 | Inj Romiplostim 250 mcg | Inj Romiplostim 250 mcg | 72 | vial | consignee2dglp | 30 |
| 28 | Inj Romiplostim 125 mg | Inj Romiplostim 125 mg | 150 | vial | consignee2dglp | 30 |
| 29 | Inj Thiotepa 100 mg | Inj Thiotepa 100 mg | 6 | amp | consignee2dglp | 30 |
| 30 | Inj Thiotepa 15 mg | Inj Thiotepa 15 mg | 6 | vial | consignee2dglp | 30 |
| 31 | Inj Treosulfan 5 gm | Inj Treosulfan 5 gm | 6 | vial | consignee2dglp | 30 |
| 32 | Tab Pomalidomide 2 mg | Tab Pomalidomide 2 mg | 1,260 | no | consignee2dglp | 30 |
| 33 | Inj Feiba 500 IU | Inj Feiba 500 IU | 12 | vial | consignee2dglp | 30 |
| 34 | Tab Posaconazole 100 mg | Tab Posaconazole 100 mg | 1,060 | nos | consignee2dglp | 30 |
| 35 | Polatuzumanb Vedotin 30 mg | Polatuzumanb Vedotin 30 mg | 6 | vial | consignee2dglp | 30 |
| 36 | Nonacog beta pegol 500 IU Lyophilized powder for solution for Injection Glycopegylated Recombinant Factor IX | Nonacog beta pegol 500 IU (Lyophilized powder for solution for Injection) Glycopegylated Recombinant Factor IX | 15 | vial | consignee2dglp | 30 |
Discover companies most likely to bid on this tender
Start
22-Aug-2025, 2:00 pm
End
06-Sep-2025, 11:00 am
Duration: 357 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Key insights about WEST BENGAL tender market
The eligibility requirements include being a registered entity qualified to supply pharmaceutical products, with valid licenses to operate within the sector. Bidders should also have experience in dealing with government contracts, particularly in providing healthcare solutions.
Selected bidders must provide various essential certificates including quality assurance certifications, product registrations with health authorities, and any other relevant documentation to demonstrate compliance with national healthcare standards.
To participate in the tender, bidders must follow a structured registration process, which includes submitting necessary documents electronically through the portal and registering their entity details to authenticate their ability to fulfill the contract obligations.
Submissions should comply with specified document formats which typically include PDF, Word, or Excel. It is crucial to ensure that all documents are clear, legible, and formatted according to the requirements outlined in the tender documents.
Micro, Small and Medium Enterprises (MSEs) have specific benefits such as reserved quotas in bidding processes and potential price preferences to encourage local participation. This initiative strengthens local industry while ensuring quality supply to military healthcare needs.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS